125 related articles for article (PubMed ID: 23674509)
1. Use of TransFix™ cerebrospinal fluid storage tubes prevents cellular loss and enhances flow cytometric detection of malignant hematological cells after 18 hours of storage.
de Jongste AH; Kraan J; van den Broek PD; Brooimans RA; Bromberg JE; van Montfort KA; Smitt PA; Gratama JW
Cytometry B Clin Cytom; 2014 Jul; 86(4):272-9. PubMed ID: 23674509
[TBL] [Abstract][Full Text] [Related]
2. Stability of canine and feline cerebrospinal fluid samples regarding total cell count and cell populations stored in "TransFix®/EDTA CSF sample storage tubes".
Meier L; Carlson R; Neßler J; Tipold A
BMC Vet Res; 2020 Dec; 16(1):487. PubMed ID: 33334339
[TBL] [Abstract][Full Text] [Related]
3. Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time.
de Graaf MT; van den Broek PD; Kraan J; Luitwieler RL; van den Bent MJ; Boonstra JG; Schmitz PI; Gratama JW; Sillevis Smitt PA
J Neurol; 2011 Aug; 258(8):1507-12. PubMed ID: 21399987
[TBL] [Abstract][Full Text] [Related]
4. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.
Bromberg JE; Breems DA; Kraan J; Bikker G; van der Holt B; Smitt PS; van den Bent MJ; van't Veer M; Gratama JW
Neurology; 2007 May; 68(20):1674-9. PubMed ID: 17502548
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometry increases the proportion of valuable samples in cerebrospinal fluid with normal cell count in malignant blood diseases].
Jara C; Veas C; Delgado C; Cabezas C; Chandía M
Rev Med Chil; 2023 May; 151(5):560-564. PubMed ID: 38687537
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric characterization of cerebrospinal fluid cells.
de Graaf MT; de Jongste AH; Kraan J; Boonstra JG; Sillevis Smitt PA; Gratama JW
Cytometry B Clin Cytom; 2011 Sep; 80(5):271-81. PubMed ID: 21567940
[TBL] [Abstract][Full Text] [Related]
7. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies.
Tawfik B; Brown L; Fuda F; Chen W; Niu S; Sailors J; Sadeghi N
Ann Hematol; 2018 Sep; 97(9):1707-1716. PubMed ID: 29680874
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy.
Collie AM; Hill BT; Stevens GH; Fenner K; Gazdick E; Hsi ED
Am J Clin Pathol; 2014 Apr; 141(4):515-21. PubMed ID: 24619752
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of cerebrospinal fluid flow cytometry in patients with and without prior hematologic malignancy.
Kovach AE; DeLelys ME; Kelliher AS; Dillon LJ; Hasserjian RP; Ferry JA; Preffer FI; Sohani AR
Am J Hematol; 2014 Oct; 89(10):978-84. PubMed ID: 25042070
[TBL] [Abstract][Full Text] [Related]
10. Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease.
Scharf EL; Hanson CA; Howard MT; Keegan BM
J Neurooncol; 2016 Aug; 129(1):77-83. PubMed ID: 27161251
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice.
Nam AS; Giorgadze T; Tam W; Chadburn A
Acta Cytol; 2018; 62(2):130-136. PubMed ID: 29510385
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia].
Jiang NG; Zhu HL; Zeng TT; Su J; Zhang Y; Jia YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):664-8. PubMed ID: 20848792
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology.
Schroers R; Baraniskin A; Heute C; Vorgerd M; Brunn A; Kuhnhenn J; Kowoll A; Alekseyev A; Schmiegel W; Schlegel U; Deckert M; Pels H
Eur J Haematol; 2010 Dec; 85(6):520-8. PubMed ID: 20727005
[TBL] [Abstract][Full Text] [Related]
14. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry.
Nückel H; Novotny JR; Noppeney R; Savidou I; Dührsen U
Clin Lab Haematol; 2006 Feb; 28(1):22-9. PubMed ID: 16430456
[TBL] [Abstract][Full Text] [Related]
15. Detection of B-cell populations with monotypic light chain expression in cerebrospinal fluid specimens from patients with multiple sclerosis by polychromatic flow cytometry.
Vafaii P; DiGiuseppe JA
Cytometry B Clin Cytom; 2014 Mar; 86(2):106-10. PubMed ID: 23818243
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome.
Cesana C; Klersy C; Scarpati B; Brando B; Faleri M; Bertani G; Gatti A; Volpato E; Barba C; Ferri U; Scampini L; Grillo G; Lando G; Nosari A; Morra E; Cairoli R
Ann Hematol; 2011 Jul; 90(7):827-35. PubMed ID: 21212952
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials.
Mexhitaj I; Lim N; Fernandez-Velasco JI; Zrzavy T; Harris KM; Muraro PA; Villar LM; Bar-Or A; Cooney LA
J Immunol Methods; 2022 Nov; 510():113344. PubMed ID: 36041516
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid findings in patients with hematologic neoplasms and meningeal infiltration.
Domingues RB; de Moura Leite FBV; Senne C
Acta Neurol Belg; 2021 Dec; 121(6):1543-1546. PubMed ID: 32519319
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies.
Galati D; Di Noto R; Del Vecchio L
Leuk Res; 2013 Mar; 37(3):231-7. PubMed ID: 23287431
[TBL] [Abstract][Full Text] [Related]
20. The influence of fixation of biological samples on cell count and marker expression stability in flow cytometric analyses.
SĘdek Ł; Kulis J; SŁota Ł; Twardoch M; Pierzyna-ŚwitaŁa M; Perkowski B; SzczepaŃski T
Cent Eur J Immunol; 2020; 45(2):206-213. PubMed ID: 33456333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
